Načítá se...
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
INTRODUCTION: The tight junction molecule Claudin 18.2 is selectively expressed in healthy and malignant gastric epithelial tissue and is a promising therapy target for high Claudin 18.2 expressing adenocarcinomas of the esophagogastric junction and stomach (AEG/S). METHODS: This study analyzed the...
Uloženo v:
| Vydáno v: | Clin Transl Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7577914/ https://ncbi.nlm.nih.gov/pubmed/32488802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-020-02380-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|